The elevations in VAP-1 may be a consequence rather than a cause of AF, or the elevation of VAP-1 levels and the occurrence of AF may both be consequences of shared inflammatory or hemodynamic pathways. This evidence concerns the gene AOC3 and atrial fibrillation.